MeAgain reviews point to a different GLP-1 need: one place for food, protein, fiber, water, medication management, injection sites, side effects, weight, and progress
Exosome serums are expensive, sometimes prohibitively so, when it comes to clinical products
Claims data (N=21,972) found that only 56% of patients on once-weekly GLP-1 agonists maintained a proportion of days covered (PDC) of 80% or higher at 12 months 8
First author on the study, Mark Lebwohl, MD, of the Icahn School of Medicine at Mount Sinai, New York, New York, and colleagues concluded, the findings from this trial support the multifaceted health benefits of concomitant therapy with [ixekizumab and tirzepatide] for treating psoriasis and management of comorbidities and may help to inform future clinical practice and guideline recommendations for these patients. Drs
It feels lucky to pick all these peoples brains